Curis
CRIS
#10257
Rank
A$31.9 M
Marketcap
A$0.80
Share price
3.17%
Change (1 day)
-61.15%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -A$50.91 Million

According to Curis's latest financial reports the company's current earnings are A$11.65 Million. In 2024 the company made an earning of -A$62.08 Million, an increase over its 2023 earnings that were of -A$65.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$50.91 Million-17.99%
2024 -A$62.08 Million-5.77%
2023 -A$65.88 Million-13.1%
2022 -A$75.81 Million27.52%
2021 -A$59.45 Million65.09%
2020 -A$36.01 Million-9.1%
2019 -A$39.61 Million-4.73%
2018 -A$41.58 Million-41.95%
2017 -A$71.62 Million-14.37%
2016 -A$83.64 Million3.55%
2015 -A$80.77 Million271.52%
2014 -A$21.74 Million76.64%
2013 -A$12.31 Million
2011 -A$10.46 Million27.76%
2010 -A$8.19 Million-43.87%
2009 -A$14.58 Million-23.44%
2008 -A$19.04 Million56.66%
2007 -A$12.16 Million-16.71%
2006 -A$14.6 Million-36.92%
2005 -A$23.13 Million156.25%
2004 -A$9.03 Million-37.24%
2003 -A$14.39 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.78 B-31,404.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.53 B-28,750.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$89.8 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.36 B-2,990.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.42 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$35.94 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA